Aurobindo Pharma gets EIR with VAI status from USFDA for Hyderabad facility

According to the US health regulator, a VAI classification "means objectionable conditions or practices were found but the agency is not prepared to take or recommend any administrative or regulatory action".

from Moneycontrol Business News https://ift.tt/32sdjPt